Business
Teva to Receive Worldwide Development and Commercial Rights to Novel CGRP Antagonists; Heptares to Receive $10 Million Upfront with up to $400 Million in...
Hi, what are you looking for?
Teva to Receive Worldwide Development and Commercial Rights to Novel CGRP Antagonists; Heptares to Receive $10 Million Upfront with up to $400 Million in...
Pfizer will hold a 10% stake in the Israeli company, as part of its acquisition of Allergan.
Impax, Stada, Taro may be takeover targets for Mylan, Perrigo; Mylan may also look for assets shed in Teva-Allergan deal
Perrigo is acquiring gastroenterology drug Entocort from AstraZeneca.
Pfizer is negotiating a price of $370 to $380 for each share, a person familiar with the discussions said.
Hospital officials from Tomsk visited Israel to scout out biomed and telemed companies for the Siberian region’s new Medicine of the Future project.
Mylan's Executive Chairman Robert Coury: we are well-positioned to quickly execute on the next strategic, value-enhancing opportunities for our business, some of which we...
Generic drug maker Mylan $26bn hostile bid for peer Perrigo looked unlikely to succeed, a few hours before it was set to expire, a...
Perrigo Company Plc, the Irish-based generic drugmaker trying to fend off a hostile bid by Mylan NV, held unsuccessful talks to acquire Endo International...
Valeant Issues Statement On Sales Of Company Stock as follow: Valeant Pharmaceuticals International, Inc. stated that 1, 297, 399 shares pledged to Goldman...